W2O Acquires Elysia Group
Thu, Sep. 24, 2020
By Kevin McCauley
W2O, the No. 1 ranked independent healthcare PR firm, has acquired Elysia Group, an economic and outcomes research outfit based in New York.
| Category: Healthcare PR | Return to Latest News |
W2O, the No. 1 ranked independent healthcare PR firm, has acquired Elysia Group, an economic and outcomes research outfit based in New York.
 |
| CVS chief communications officer Kym White talks with Doug Simon about the challenges of meeting all the messaging needs of a large, multi-faceted healthcare company in the latest “PR’s Top Pros Talk” video. |
Health insurance coverage is taking a hit due to COVID-19, and the loss of coverage is coming down hardest on Black Americans and young people, according to a new survey from Finn Partners.
Tevi Troy, who was VP public policy at Juul Labs, has signed on as advisor at Leavitt Partners, the intelligence gathering and consulting shop that helps clients navigate the rapidly changing healthcare market.
As healthcare providers increasingly depend on personal health data to fuel such services as COVID trackers, consumers are concerned about how much control they have over that data, according to a new study from W2O.
Germany's Bayer recruits Lori Moore, a veteran of Novo Nordisk and Sanofi, as VP, head of US pharmaceutical communications.
Finn Partners is working with the Africa Medical Supplies Platform, a non-profit initiative launched by the African Union in response to the COVID-19 pandemic.
Moderna, the Cambridge, MA-based biotech with a promising COVID-19 vaccine in development, has hired Avenue Solutions for DC representation.
Ray Jordan, who held top PR jobs at Amgen, Johnson & Johson and Pfizer, has joined biotech firm Moderna, which has developed the first US COVID-19 vaccine to post positive trial results. (1 reader comment)
 |
| Y&R PR chief executive officer Olga Fleming talks about the importance of community, empathy and committing to both words and actions. |
UK-based Huntsworth has acquired Cormis, healthcare strategic communications & medical staff training shop. Deal marks first acquisition under ownership of Clayton, Dubilier & Rice investment firm.
Sard Verbinnen & Co. represents Premier Biotech, which gained FDA nod to distribute COVID-19 antibodies test made by Chinese company.
 |
| The impact of COVID-19 on healthcare PR is examined with Finn Partners managing partner, global health Gil Bashe and St. Jude Children’s Research Hospital director of media relations Marvin Stockwell. |
Bryan Specht, one-time president of Olson, has joined W2O Group to accelerate its transformation to a digital healthcare firm.
Imre Health has recruited Digitas Health's Shane McDevitt as director of its new medical and scientific affairs unit.
Emergent BioSolutions, life sciences company that is engaged in the fight against COVID-19, has hired Nina DeLorenzo as senior VP-global public affairs.
Teneo represents Bloom Energy, which is teaming with Almo Corp, to refurbish and distribute unused and out-or-warranty ventilators to states and hospitals in the fight against the COVID-19 pandemic.
CG Life has acquired Philadelphia-based scientific PR and technical marketing agency McDAY.
Kaiser Permanente chief communications officer Kathryn Beiser is headed to Eli Lilly and Company, where she will take the position of VP, global communications, effective April 6.
1AB strategic communications shop is handling Moderna Therapeutics, which on March 16 began the first US clinical trial for a coronavirus vaccine.
M Booth Health recruits Karen Strauss, a 30-year veteran of Ketchum, for chief strategy & innovation officer slot, a new post.
Finn Partners today unveiled the Finn wellness collaborative to join leaders in its consumer, health and travel & lifestyle practices across regions to increase the independent firm's share of the $4.5T wellness category.
As the new decade dawns, here are some of the anticipated changes in health communications as well as potential opportunities for improving health in the 2020s.
| More » |
